| Financial Year |
March 31 2023 |
| Monetary Funds |
111,699,217.85 |
| Held-for-trading Financial Assets |
38,368,277.64 |
| Notes Receivable |
20,388.59 |
| Accounts Receivable |
168,429,541.80 |
| Advances to Suppliers |
23,901,347.80 |
| Other Receivables |
25,280,712.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
99,219,380.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,890.02 |
| Total Current Assets |
466,966,756.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
28,936,861.11 |
| Fixed Assetes |
77,642,964.67 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,563,701.08 |
| R&D expenses |
3,392,322.45 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,148,773.29 |
| Deferred Income Tax Assets |
2,080,299.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
166,004,457.11 |
| Total Assets |
632,971,214.00 |
| Short-Term Loans |
318,171,869.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
32,188,401.27 |
| Accounts Payable |
108,168,814.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
529,085.27 |
| Taxes Payable |
4,204,299.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,062,046.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,395,095.55 |
| Other Current Liabilities |
999,950.73 |
| Sub-Total of Current Liabilities |
486,728,694.24 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,521,473.17 |
| Other Non-Current Liabilities |
235,541.48 |
| Sub-Total of Non-Current Liabilities |
22,555,319.46 |
| Total Liabilities |
509,284,013.70 |
| Paid-In Capital(Or Share Stock) |
161,070,000.00 |
| Capital Surplus |
135,934,113.31 |
| Surplus Reserve |
13,438,289.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-189,625,202.78 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
123,687,200.30 |
| Owner's Equity（Stockholder's Equity） |
123,687,200.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
632,971,214.00 |
